Patents by Inventor Lane Desborough

Lane Desborough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11903698
    Abstract: Disclosed are methods, apparatuses, etc. for determination and application of a metric for assessing a patient's glycemic health. In one particular implementation, a computed metric may be used to balance short-term and long-term risks associated with a particular therapy.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: February 20, 2024
    Assignee: Medtronic Minimed, Inc.
    Inventors: Lane Desborough, Cesar C. Palerm, Salman Monirabbasi
  • Patent number: 11896797
    Abstract: One or more embodiments of the disclosure relate, generally, to a pen cap for a manual insulin delivery device. Such a pen cap may include a wireless communication interface, a detection circuit, a user interface, and a processor and memory. The detection circuit may be configured to detect cappings and decappings of the pen cap from a manual insulin delivery device. Timing information and recommendations related to capping and decapping of the pen cap may be presented to a user.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: February 13, 2024
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11857763
    Abstract: A method may include displaying to a user an interface at which the user inputs a fear of hypoglycemia index (FHI), the FHI corresponding to an acceptable probability of a blood glucose level being below a threshold blood glucose level. The method may also include receiving blood glucose data for a person with diabetes (PWD). The method may additionally include calculating a probability of the PWD having a blood glucose level below the threshold blood glucose level based on the variability of the received blood glucose data. The method may also include setting one or more target blood glucose levels to align the probability of the PWD having a blood glucose level below the threshold blood glucose level with the acceptable probability associated with the user input FHI. The method may additionally include delivering insulin, using the insulin delivery device, based on the target blood glucose level.
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: January 2, 2024
    Assignee: Insulet Corporation
    Inventors: Lane Desborough, Bryan Mazlish
  • Patent number: 11844923
    Abstract: One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.
    Type: Grant
    Filed: July 21, 2021
    Date of Patent: December 19, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11806514
    Abstract: One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: November 7, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Per John Sjolund, Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor
  • Publication number: 20230330334
    Abstract: According to some embodiments, an insulin management method implemented by an insulin delivery system is provided. The method includes determining an assumed insulin on board based on an assumed external dose calculated to correct an initial blood glucose value of the user to a target blood glucose. The method includes delivering insulin from an insulin delivery device with the insulin in the form of a plurality of correction bolus doses during a fasting period in response to received blood glucose measurements, the correction bolus doses compensated for by a determined insulin on board, wherein for at least a first correction bolus dose of the plurality of correction bolus doses the determined insulin on board equals the assumed insulin on board. Other systems, devices and methods are also provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: October 19, 2023
    Inventors: Per John Sjolund, Sean Thomas Saint, Jack David Pryor, Lane Desborough
  • Publication number: 20230330336
    Abstract: An insulin management method is provided. The method includes providing an insulin delivery device, wherein the insulin delivery device is in the form of an automatic insulin delivery device attachable to a user's body for the duration of a fasting period. The method includes delivering insulin from the insulin delivery device during the fasting period within an overall time period in the form of correction bolus doses of insulin in response to received blood glucose measurements. The insulin delivery device refrains from administering basal insulin at a preset or default rate or in a preset or default pattern. Insulin is received by the user from a non-fasting insulin management modality during a non-fasting period within the overall time period and the non-fasting insulin management modality provides at least one of a basal dose of insulin and bolus doses of insulin. Other methods, devices and systems are also provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: October 19, 2023
    Inventors: Per John Sjolund, Sean Thomas Saint, Jack David Pryor, Lane Desborough
  • Publication number: 20230330335
    Abstract: An insulin management method implemented by an insulin delivery device is provided. The method includes detecting a starting activity associated with preparation of use of the insulin delivery device in the form of an automatic insulin delivery device attachable to a user's body for a duration of a fasting period within an overall time period. The method includes initiating automated delivery of insulin in the form correction bolus doses in response to periodically received blood glucose measurements during the fasting period. Other methods, devices and systems are also provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: October 19, 2023
    Inventors: Per John Sjolund, Sean Thomas Saint, Jack David Pryor, Lane Desborough
  • Patent number: 11771835
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: October 3, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Publication number: 20230173176
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.
    Type: Application
    Filed: January 31, 2023
    Publication date: June 8, 2023
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20230098036
    Abstract: Methods of insulin delivery may include Selecting a basal insulin delivery rate responsive to a projected blood glucose level that approximates a target blood glucose level. Methods of insulin delivery may further include generating insulin delivery instructions for an insulin delivery device, the insulin delivery instructions corresponding to the basal insulin delivery rate and for a variable time duration relative to an intended time duration.
    Type: Application
    Filed: November 29, 2022
    Publication date: March 30, 2023
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20230064614
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. Such a diabetes management system may include a flash glucose monitor and a user interface. The user interface may be configured to display one or more of graphical representations of glucose values and value representative of glucose measurements, and to change values displayed responsive to user interaction with the user interface.
    Type: Application
    Filed: October 10, 2022
    Publication date: March 2, 2023
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11565045
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: January 31, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20230009339
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.
    Type: Application
    Filed: September 19, 2022
    Publication date: January 12, 2023
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 11547805
    Abstract: One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: January 10, 2023
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11511039
    Abstract: Methods of insulin delivery may include obtaining one or more blood glucose readings from a flash glucose monitor, where the blood glucose readings may be obtained in response to a user invocation of the flash glucose monitor. The method may also include generating multiple insulin delivery profiles of insulin delivery actions over multiple diurnal time segments based on the one or more blood glucose readings. The method may additionally include selecting one of the delivery profiles that is projected to approximate a target blood glucose level, and delivering insulin according to the selected delivery profile. Systems may provide such insulin delivery.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: November 29, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20220339364
    Abstract: Diabetes management systems may include a glucose monitoring device adapted to transmit glucose data and at least one accessory in communication with the glucose monitoring device and adapted to provide at least one alarm or alert based on the glucose data.
    Type: Application
    Filed: July 11, 2022
    Publication date: October 27, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 11464459
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. Such a diabetes management system may include a flash glucose monitor and a user interface. The user interface may be configured to display one or more of graphical representations of glucose values and value representative of glucose measurements, and to change values displayed responsive to user interaction with the user interface.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: October 11, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20220305195
    Abstract: One or more embodiments relate, generally, to a reusable accessory for a medication injection pen. Such a reusable accessory may be adapted to be reversibly attached to a medication injection pen, and configured to detect an event associated with an injection of medication from the medication injection pen. It may also be configured to determine a percentage of medication that remains active for injection by the medication injection pen based on timing information and dosing event information.
    Type: Application
    Filed: June 14, 2022
    Publication date: September 29, 2022
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20220305212
    Abstract: One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.
    Type: Application
    Filed: June 14, 2022
    Publication date: September 29, 2022
    Inventors: Per John Sjolund, Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor